Home › Trial NCT07746245
The Efficacy of CAPCT in Patients With PTCL
- Trial IDNCT07746245
- StatusNot Yet Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorThe First Affiliated Hospital with Nanjing Medical University
- Enrollment58
- Start date2026-08-01
- ConditionsPeripheral T-Cell Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.